Global Dog Prescription Drugs Market Insights, Forecast to 2026
Dog Prescription Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dog Prescription Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Dog Prescription Drugs market is segmented into
The Dog Prescription Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dog Prescription Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dog Prescription Drugs Market Share Analysis
Dog Prescription Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dog Prescription Drugs business, the date to enter into the Dog Prescription Drugs market, Dog Prescription Drugs product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Dog Prescription Drugs market is segmented into
- Oral Type
- Smear Type
- Injection Type
- Spray Type
- Hospital
- Clinic
- Others
The Dog Prescription Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dog Prescription Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dog Prescription Drugs Market Share Analysis
Dog Prescription Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dog Prescription Drugs business, the date to enter into the Dog Prescription Drugs market, Dog Prescription Drugs product introduction, recent developments, etc.
The major vendors covered:
- Elanco Animal Health
- Ceva Sante Animale
- MSD Animal Health
- Zoetis
- Virbac
- Dechra
- Vetoquinol
- Animalcare Group
- Ourofino Saude Animal
- Boehringer Ingelheim
1 STUDY COVERAGE
1.1 Dog Prescription Drugs Product Introduction
1.2 Market Segments
1.3 Key Dog Prescription Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dog Prescription Drugs Market Size Growth Rate by Type
1.4.2 Oral Type
1.4.3 Smear Type
1.4.4 Injection Type
1.4.5 Spray Type
1.5 Market by Application
1.5.1 Global Dog Prescription Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Dog Prescription Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Dog Prescription Drugs Industry
1.6.1.1 Dog Prescription Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Dog Prescription Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Dog Prescription Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Dog Prescription Drugs Market Size Estimates and Forecasts
2.1.1 Global Dog Prescription Drugs Revenue 2015-2026
2.1.2 Global Dog Prescription Drugs Sales 2015-2026
2.2 Dog Prescription Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Dog Prescription Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dog Prescription Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL DOG PRESCRIPTION DRUGS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Dog Prescription Drugs Sales by Manufacturers
3.1.1 Dog Prescription Drugs Sales by Manufacturers (2015-2020)
3.1.2 Dog Prescription Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Dog Prescription Drugs Revenue by Manufacturers
3.2.1 Dog Prescription Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Dog Prescription Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dog Prescription Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dog Prescription Drugs Revenue in 2019
3.2.5 Global Dog Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dog Prescription Drugs Price by Manufacturers
3.4 Dog Prescription Drugs Manufacturing Base Distribution, Product Types
3.4.1 Dog Prescription Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dog Prescription Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Dog Prescription Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Dog Prescription Drugs Market Size by Type (2015-2020)
4.1.1 Global Dog Prescription Drugs Sales by Type (2015-2020)
4.1.2 Global Dog Prescription Drugs Revenue by Type (2015-2020)
4.1.3 Dog Prescription Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dog Prescription Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Dog Prescription Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Dog Prescription Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Dog Prescription Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dog Prescription Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Dog Prescription Drugs Market Size by Application (2015-2020)
5.1.1 Global Dog Prescription Drugs Sales by Application (2015-2020)
5.1.2 Global Dog Prescription Drugs Revenue by Application (2015-2020)
5.1.3 Dog Prescription Drugs Price by Application (2015-2020)
5.2 Dog Prescription Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Dog Prescription Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Dog Prescription Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Dog Prescription Drugs Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Dog Prescription Drugs by Country
6.1.1 North America Dog Prescription Drugs Sales by Country
6.1.2 North America Dog Prescription Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dog Prescription Drugs Market Facts & Figures by Type
6.3 North America Dog Prescription Drugs Market Facts & Figures by Application
7 EUROPE
7.1 Europe Dog Prescription Drugs by Country
7.1.1 Europe Dog Prescription Drugs Sales by Country
7.1.2 Europe Dog Prescription Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dog Prescription Drugs Market Facts & Figures by Type
7.3 Europe Dog Prescription Drugs Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Dog Prescription Drugs by Region
8.1.1 Asia Pacific Dog Prescription Drugs Sales by Region
8.1.2 Asia Pacific Dog Prescription Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dog Prescription Drugs Market Facts & Figures by Type
8.3 Asia Pacific Dog Prescription Drugs Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Dog Prescription Drugs by Country
9.1.1 Latin America Dog Prescription Drugs Sales by Country
9.1.2 Latin America Dog Prescription Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dog Prescription Drugs Market Facts & Figures by Type
9.3 Central & South America Dog Prescription Drugs Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Dog Prescription Drugs by Country
10.1.1 Middle East and Africa Dog Prescription Drugs Sales by Country
10.1.2 Middle East and Africa Dog Prescription Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dog Prescription Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Dog Prescription Drugs Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Elanco Animal Health
11.1.1 Elanco Animal Health Corporation Information
11.1.2 Elanco Animal Health Description, Business Overview and Total Revenue
11.1.3 Elanco Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Elanco Animal Health Dog Prescription Drugs Products Offered
11.1.5 Elanco Animal Health Recent Development
11.2 Ceva Sante Animale
11.2.1 Ceva Sante Animale Corporation Information
11.2.2 Ceva Sante Animale Description, Business Overview and Total Revenue
11.2.3 Ceva Sante Animale Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Ceva Sante Animale Dog Prescription Drugs Products Offered
11.2.5 Ceva Sante Animale Recent Development
11.3 MSD Animal Health
11.3.1 MSD Animal Health Corporation Information
11.3.2 MSD Animal Health Description, Business Overview and Total Revenue
11.3.3 MSD Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.3.4 MSD Animal Health Dog Prescription Drugs Products Offered
11.3.5 MSD Animal Health Recent Development
11.4 Zoetis
11.4.1 Zoetis Corporation Information
11.4.2 Zoetis Description, Business Overview and Total Revenue
11.4.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Zoetis Dog Prescription Drugs Products Offered
11.4.5 Zoetis Recent Development
11.5 Virbac
11.5.1 Virbac Corporation Information
11.5.2 Virbac Description, Business Overview and Total Revenue
11.5.3 Virbac Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Virbac Dog Prescription Drugs Products Offered
11.5.5 Virbac Recent Development
11.6 Dechra
11.6.1 Dechra Corporation Information
11.6.2 Dechra Description, Business Overview and Total Revenue
11.6.3 Dechra Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Dechra Dog Prescription Drugs Products Offered
11.6.5 Dechra Recent Development
11.7 Vetoquinol
11.7.1 Vetoquinol Corporation Information
11.7.2 Vetoquinol Description, Business Overview and Total Revenue
11.7.3 Vetoquinol Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Vetoquinol Dog Prescription Drugs Products Offered
11.7.5 Vetoquinol Recent Development
11.8 Animalcare Group
11.8.1 Animalcare Group Corporation Information
11.8.2 Animalcare Group Description, Business Overview and Total Revenue
11.8.3 Animalcare Group Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Animalcare Group Dog Prescription Drugs Products Offered
11.8.5 Animalcare Group Recent Development
11.9 Ourofino Saude Animal
11.9.1 Ourofino Saude Animal Corporation Information
11.9.2 Ourofino Saude Animal Description, Business Overview and Total Revenue
11.9.3 Ourofino Saude Animal Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Ourofino Saude Animal Dog Prescription Drugs Products Offered
11.9.5 Ourofino Saude Animal Recent Development
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Corporation Information
11.10.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.10.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Boehringer Ingelheim Dog Prescription Drugs Products Offered
11.10.5 Boehringer Ingelheim Recent Development
11.1 Elanco Animal Health
11.1.1 Elanco Animal Health Corporation Information
11.1.2 Elanco Animal Health Description, Business Overview and Total Revenue
11.1.3 Elanco Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Elanco Animal Health Dog Prescription Drugs Products Offered
11.1.5 Elanco Animal Health Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Dog Prescription Drugs Market Estimates and Projections by Region
12.1.1 Global Dog Prescription Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Dog Prescription Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Dog Prescription Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Dog Prescription Drugs Sales Forecast (2021-2026)
12.2.2 North America: Dog Prescription Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Dog Prescription Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Dog Prescription Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Dog Prescription Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Dog Prescription Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Dog Prescription Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dog Prescription Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dog Prescription Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dog Prescription Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dog Prescription Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Dog Prescription Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Dog Prescription Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Dog Prescription Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Dog Prescription Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dog Prescription Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dog Prescription Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dog Prescription Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dog Prescription Drugs Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Dog Prescription Drugs Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Dog Prescription Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Dog Prescription Drugs Product Introduction
1.2 Market Segments
1.3 Key Dog Prescription Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dog Prescription Drugs Market Size Growth Rate by Type
1.4.2 Oral Type
1.4.3 Smear Type
1.4.4 Injection Type
1.4.5 Spray Type
1.5 Market by Application
1.5.1 Global Dog Prescription Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Dog Prescription Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Dog Prescription Drugs Industry
1.6.1.1 Dog Prescription Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Dog Prescription Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Dog Prescription Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Dog Prescription Drugs Market Size Estimates and Forecasts
2.1.1 Global Dog Prescription Drugs Revenue 2015-2026
2.1.2 Global Dog Prescription Drugs Sales 2015-2026
2.2 Dog Prescription Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Dog Prescription Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dog Prescription Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL DOG PRESCRIPTION DRUGS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Dog Prescription Drugs Sales by Manufacturers
3.1.1 Dog Prescription Drugs Sales by Manufacturers (2015-2020)
3.1.2 Dog Prescription Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Dog Prescription Drugs Revenue by Manufacturers
3.2.1 Dog Prescription Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Dog Prescription Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dog Prescription Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dog Prescription Drugs Revenue in 2019
3.2.5 Global Dog Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dog Prescription Drugs Price by Manufacturers
3.4 Dog Prescription Drugs Manufacturing Base Distribution, Product Types
3.4.1 Dog Prescription Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dog Prescription Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Dog Prescription Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Dog Prescription Drugs Market Size by Type (2015-2020)
4.1.1 Global Dog Prescription Drugs Sales by Type (2015-2020)
4.1.2 Global Dog Prescription Drugs Revenue by Type (2015-2020)
4.1.3 Dog Prescription Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dog Prescription Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Dog Prescription Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Dog Prescription Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Dog Prescription Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dog Prescription Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Dog Prescription Drugs Market Size by Application (2015-2020)
5.1.1 Global Dog Prescription Drugs Sales by Application (2015-2020)
5.1.2 Global Dog Prescription Drugs Revenue by Application (2015-2020)
5.1.3 Dog Prescription Drugs Price by Application (2015-2020)
5.2 Dog Prescription Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Dog Prescription Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Dog Prescription Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Dog Prescription Drugs Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Dog Prescription Drugs by Country
6.1.1 North America Dog Prescription Drugs Sales by Country
6.1.2 North America Dog Prescription Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dog Prescription Drugs Market Facts & Figures by Type
6.3 North America Dog Prescription Drugs Market Facts & Figures by Application
7 EUROPE
7.1 Europe Dog Prescription Drugs by Country
7.1.1 Europe Dog Prescription Drugs Sales by Country
7.1.2 Europe Dog Prescription Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dog Prescription Drugs Market Facts & Figures by Type
7.3 Europe Dog Prescription Drugs Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Dog Prescription Drugs by Region
8.1.1 Asia Pacific Dog Prescription Drugs Sales by Region
8.1.2 Asia Pacific Dog Prescription Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dog Prescription Drugs Market Facts & Figures by Type
8.3 Asia Pacific Dog Prescription Drugs Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Dog Prescription Drugs by Country
9.1.1 Latin America Dog Prescription Drugs Sales by Country
9.1.2 Latin America Dog Prescription Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dog Prescription Drugs Market Facts & Figures by Type
9.3 Central & South America Dog Prescription Drugs Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Dog Prescription Drugs by Country
10.1.1 Middle East and Africa Dog Prescription Drugs Sales by Country
10.1.2 Middle East and Africa Dog Prescription Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dog Prescription Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Dog Prescription Drugs Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Elanco Animal Health
11.1.1 Elanco Animal Health Corporation Information
11.1.2 Elanco Animal Health Description, Business Overview and Total Revenue
11.1.3 Elanco Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Elanco Animal Health Dog Prescription Drugs Products Offered
11.1.5 Elanco Animal Health Recent Development
11.2 Ceva Sante Animale
11.2.1 Ceva Sante Animale Corporation Information
11.2.2 Ceva Sante Animale Description, Business Overview and Total Revenue
11.2.3 Ceva Sante Animale Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Ceva Sante Animale Dog Prescription Drugs Products Offered
11.2.5 Ceva Sante Animale Recent Development
11.3 MSD Animal Health
11.3.1 MSD Animal Health Corporation Information
11.3.2 MSD Animal Health Description, Business Overview and Total Revenue
11.3.3 MSD Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.3.4 MSD Animal Health Dog Prescription Drugs Products Offered
11.3.5 MSD Animal Health Recent Development
11.4 Zoetis
11.4.1 Zoetis Corporation Information
11.4.2 Zoetis Description, Business Overview and Total Revenue
11.4.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Zoetis Dog Prescription Drugs Products Offered
11.4.5 Zoetis Recent Development
11.5 Virbac
11.5.1 Virbac Corporation Information
11.5.2 Virbac Description, Business Overview and Total Revenue
11.5.3 Virbac Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Virbac Dog Prescription Drugs Products Offered
11.5.5 Virbac Recent Development
11.6 Dechra
11.6.1 Dechra Corporation Information
11.6.2 Dechra Description, Business Overview and Total Revenue
11.6.3 Dechra Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Dechra Dog Prescription Drugs Products Offered
11.6.5 Dechra Recent Development
11.7 Vetoquinol
11.7.1 Vetoquinol Corporation Information
11.7.2 Vetoquinol Description, Business Overview and Total Revenue
11.7.3 Vetoquinol Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Vetoquinol Dog Prescription Drugs Products Offered
11.7.5 Vetoquinol Recent Development
11.8 Animalcare Group
11.8.1 Animalcare Group Corporation Information
11.8.2 Animalcare Group Description, Business Overview and Total Revenue
11.8.3 Animalcare Group Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Animalcare Group Dog Prescription Drugs Products Offered
11.8.5 Animalcare Group Recent Development
11.9 Ourofino Saude Animal
11.9.1 Ourofino Saude Animal Corporation Information
11.9.2 Ourofino Saude Animal Description, Business Overview and Total Revenue
11.9.3 Ourofino Saude Animal Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Ourofino Saude Animal Dog Prescription Drugs Products Offered
11.9.5 Ourofino Saude Animal Recent Development
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Corporation Information
11.10.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.10.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Boehringer Ingelheim Dog Prescription Drugs Products Offered
11.10.5 Boehringer Ingelheim Recent Development
11.1 Elanco Animal Health
11.1.1 Elanco Animal Health Corporation Information
11.1.2 Elanco Animal Health Description, Business Overview and Total Revenue
11.1.3 Elanco Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Elanco Animal Health Dog Prescription Drugs Products Offered
11.1.5 Elanco Animal Health Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Dog Prescription Drugs Market Estimates and Projections by Region
12.1.1 Global Dog Prescription Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Dog Prescription Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Dog Prescription Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Dog Prescription Drugs Sales Forecast (2021-2026)
12.2.2 North America: Dog Prescription Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Dog Prescription Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Dog Prescription Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Dog Prescription Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Dog Prescription Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Dog Prescription Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dog Prescription Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dog Prescription Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dog Prescription Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dog Prescription Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Dog Prescription Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Dog Prescription Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Dog Prescription Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Dog Prescription Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dog Prescription Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dog Prescription Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dog Prescription Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dog Prescription Drugs Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Dog Prescription Drugs Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Dog Prescription Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Dog Prescription Drugs Market Segments
Table 2. Ranking of Global Top Dog Prescription Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dog Prescription Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral Type
Table 5. Major Manufacturers of Smear Type
Table 6. Major Manufacturers of Injection Type
Table 7. Major Manufacturers of Spray Type
Table 8. COVID-19 Impact Global Market: (Four Dog Prescription Drugs Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Dog Prescription Drugs Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Dog Prescription Drugs Players to Combat Covid-19 Impact
Table 13. Global Dog Prescription Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Dog Prescription Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Dog Prescription Drugs Sales by Regions 2015-2020 (K Units)
Table 16. Global Dog Prescription Drugs Sales Market Share by Regions (2015-2020)
Table 17. Global Dog Prescription Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Dog Prescription Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Dog Prescription Drugs Sales Share by Manufacturers (2015-2020)
Table 20. Global Dog Prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Dog Prescription Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dog Prescription Drugs as of 2019)
Table 22. Dog Prescription Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Dog Prescription Drugs Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Dog Prescription Drugs Price (2015-2020) (USD/Unit)
Table 25. Dog Prescription Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Dog Prescription Drugs Product Type
Table 27. Date of International Manufacturers Enter into Dog Prescription Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Dog Prescription Drugs Sales by Type (2015-2020) (K Units)
Table 30. Global Dog Prescription Drugs Sales Share by Type (2015-2020)
Table 31. Global Dog Prescription Drugs Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Dog Prescription Drugs Revenue Share by Type (2015-2020)
Table 33. Dog Prescription Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Dog Prescription Drugs Sales by Application (2015-2020) (K Units)
Table 35. Global Dog Prescription Drugs Sales Share by Application (2015-2020)
Table 36. North America Dog Prescription Drugs Sales by Country (2015-2020) (K Units)
Table 37. North America Dog Prescription Drugs Sales Market Share by Country (2015-2020)
Table 38. North America Dog Prescription Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Dog Prescription Drugs Revenue Market Share by Country (2015-2020)
Table 40. North America Dog Prescription Drugs Sales by Type (2015-2020) (K Units)
Table 41. North America Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 42. North America Dog Prescription Drugs Sales by Application (2015-2020) (K Units)
Table 43. North America Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 44. Europe Dog Prescription Drugs Sales by Country (2015-2020) (K Units)
Table 45. Europe Dog Prescription Drugs Sales Market Share by Country (2015-2020)
Table 46. Europe Dog Prescription Drugs Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Dog Prescription Drugs Revenue Market Share by Country (2015-2020)
Table 48. Europe Dog Prescription Drugs Sales by Type (2015-2020) (K Units)
Table 49. Europe Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 50. Europe Dog Prescription Drugs Sales by Application (2015-2020) (K Units)
Table 51. Europe Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Dog Prescription Drugs Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Dog Prescription Drugs Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Dog Prescription Drugs Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Dog Prescription Drugs Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Dog Prescription Drugs Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Dog Prescription Drugs Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 60. Latin America Dog Prescription Drugs Sales by Country (2015-2020) (K Units)
Table 61. Latin America Dog Prescription Drugs Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Dog Prescription Drugs Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Dog Prescription Drugs Revenue Market Share by Country (2015-2020)
Table 64. Latin America Dog Prescription Drugs Sales by Type (2015-2020) (K Units)
Table 65. Latin America Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 66. Latin America Dog Prescription Drugs Sales by Application (2015-2020) (K Units)
Table 67. Latin America Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Dog Prescription Drugs Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Dog Prescription Drugs Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Dog Prescription Drugs Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Dog Prescription Drugs Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Dog Prescription Drugs Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Dog Prescription Drugs Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 76. Elanco Animal Health Corporation Information
Table 77. Elanco Animal Health Description and Major Businesses
Table 78. Elanco Animal Health Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Elanco Animal Health Product
Table 80. Elanco Animal Health Recent Development
Table 81. Ceva Sante Animale Corporation Information
Table 82. Ceva Sante Animale Description and Major Businesses
Table 83. Ceva Sante Animale Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Ceva Sante Animale Product
Table 85. Ceva Sante Animale Recent Development
Table 86. MSD Animal Health Corporation Information
Table 87. MSD Animal Health Description and Major Businesses
Table 88. MSD Animal Health Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. MSD Animal Health Product
Table 90. MSD Animal Health Recent Development
Table 91. Zoetis Corporation Information
Table 92. Zoetis Description and Major Businesses
Table 93. Zoetis Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Zoetis Product
Table 95. Zoetis Recent Development
Table 96. Virbac Corporation Information
Table 97. Virbac Description and Major Businesses
Table 98. Virbac Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Virbac Product
Table 100. Virbac Recent Development
Table 101. Dechra Corporation Information
Table 102. Dechra Description and Major Businesses
Table 103. Dechra Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Dechra Product
Table 105. Dechra Recent Development
Table 106. Vetoquinol Corporation Information
Table 107. Vetoquinol Description and Major Businesses
Table 108. Vetoquinol Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Vetoquinol Product
Table 110. Vetoquinol Recent Development
Table 111. Animalcare Group Corporation Information
Table 112. Animalcare Group Description and Major Businesses
Table 113. Animalcare Group Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Animalcare Group Product
Table 115. Animalcare Group Recent Development
Table 116. Ourofino Saude Animal Corporation Information
Table 117. Ourofino Saude Animal Description and Major Businesses
Table 118. Ourofino Saude Animal Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Ourofino Saude Animal Product
Table 120. Ourofino Saude Animal Recent Development
Table 121. Boehringer Ingelheim Corporation Information
Table 122. Boehringer Ingelheim Description and Major Businesses
Table 123. Boehringer Ingelheim Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Boehringer Ingelheim Product
Table 125. Boehringer Ingelheim Recent Development
Table 126. Global Dog Prescription Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 127. Global Dog Prescription Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Dog Prescription Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Dog Prescription Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Dog Prescription Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 131. North America: Dog Prescription Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Dog Prescription Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 133. Europe: Dog Prescription Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Dog Prescription Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 135. Asia Pacific: Dog Prescription Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Dog Prescription Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 137. Latin America: Dog Prescription Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Dog Prescription Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 139. Middle East and Africa: Dog Prescription Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Dog Prescription Drugs Players
Table 144. Dog Prescription Drugs Customers List
Table 145. Dog Prescription Drugs Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 1. Dog Prescription Drugs Market Segments
Table 2. Ranking of Global Top Dog Prescription Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dog Prescription Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral Type
Table 5. Major Manufacturers of Smear Type
Table 6. Major Manufacturers of Injection Type
Table 7. Major Manufacturers of Spray Type
Table 8. COVID-19 Impact Global Market: (Four Dog Prescription Drugs Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Dog Prescription Drugs Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Dog Prescription Drugs Players to Combat Covid-19 Impact
Table 13. Global Dog Prescription Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Dog Prescription Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Dog Prescription Drugs Sales by Regions 2015-2020 (K Units)
Table 16. Global Dog Prescription Drugs Sales Market Share by Regions (2015-2020)
Table 17. Global Dog Prescription Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Dog Prescription Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Dog Prescription Drugs Sales Share by Manufacturers (2015-2020)
Table 20. Global Dog Prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Dog Prescription Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dog Prescription Drugs as of 2019)
Table 22. Dog Prescription Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Dog Prescription Drugs Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Dog Prescription Drugs Price (2015-2020) (USD/Unit)
Table 25. Dog Prescription Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Dog Prescription Drugs Product Type
Table 27. Date of International Manufacturers Enter into Dog Prescription Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Dog Prescription Drugs Sales by Type (2015-2020) (K Units)
Table 30. Global Dog Prescription Drugs Sales Share by Type (2015-2020)
Table 31. Global Dog Prescription Drugs Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Dog Prescription Drugs Revenue Share by Type (2015-2020)
Table 33. Dog Prescription Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Dog Prescription Drugs Sales by Application (2015-2020) (K Units)
Table 35. Global Dog Prescription Drugs Sales Share by Application (2015-2020)
Table 36. North America Dog Prescription Drugs Sales by Country (2015-2020) (K Units)
Table 37. North America Dog Prescription Drugs Sales Market Share by Country (2015-2020)
Table 38. North America Dog Prescription Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Dog Prescription Drugs Revenue Market Share by Country (2015-2020)
Table 40. North America Dog Prescription Drugs Sales by Type (2015-2020) (K Units)
Table 41. North America Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 42. North America Dog Prescription Drugs Sales by Application (2015-2020) (K Units)
Table 43. North America Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 44. Europe Dog Prescription Drugs Sales by Country (2015-2020) (K Units)
Table 45. Europe Dog Prescription Drugs Sales Market Share by Country (2015-2020)
Table 46. Europe Dog Prescription Drugs Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Dog Prescription Drugs Revenue Market Share by Country (2015-2020)
Table 48. Europe Dog Prescription Drugs Sales by Type (2015-2020) (K Units)
Table 49. Europe Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 50. Europe Dog Prescription Drugs Sales by Application (2015-2020) (K Units)
Table 51. Europe Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Dog Prescription Drugs Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Dog Prescription Drugs Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Dog Prescription Drugs Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Dog Prescription Drugs Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Dog Prescription Drugs Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Dog Prescription Drugs Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 60. Latin America Dog Prescription Drugs Sales by Country (2015-2020) (K Units)
Table 61. Latin America Dog Prescription Drugs Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Dog Prescription Drugs Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Dog Prescription Drugs Revenue Market Share by Country (2015-2020)
Table 64. Latin America Dog Prescription Drugs Sales by Type (2015-2020) (K Units)
Table 65. Latin America Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 66. Latin America Dog Prescription Drugs Sales by Application (2015-2020) (K Units)
Table 67. Latin America Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Dog Prescription Drugs Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Dog Prescription Drugs Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Dog Prescription Drugs Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Dog Prescription Drugs Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Dog Prescription Drugs Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Dog Prescription Drugs Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 76. Elanco Animal Health Corporation Information
Table 77. Elanco Animal Health Description and Major Businesses
Table 78. Elanco Animal Health Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Elanco Animal Health Product
Table 80. Elanco Animal Health Recent Development
Table 81. Ceva Sante Animale Corporation Information
Table 82. Ceva Sante Animale Description and Major Businesses
Table 83. Ceva Sante Animale Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Ceva Sante Animale Product
Table 85. Ceva Sante Animale Recent Development
Table 86. MSD Animal Health Corporation Information
Table 87. MSD Animal Health Description and Major Businesses
Table 88. MSD Animal Health Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. MSD Animal Health Product
Table 90. MSD Animal Health Recent Development
Table 91. Zoetis Corporation Information
Table 92. Zoetis Description and Major Businesses
Table 93. Zoetis Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Zoetis Product
Table 95. Zoetis Recent Development
Table 96. Virbac Corporation Information
Table 97. Virbac Description and Major Businesses
Table 98. Virbac Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Virbac Product
Table 100. Virbac Recent Development
Table 101. Dechra Corporation Information
Table 102. Dechra Description and Major Businesses
Table 103. Dechra Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Dechra Product
Table 105. Dechra Recent Development
Table 106. Vetoquinol Corporation Information
Table 107. Vetoquinol Description and Major Businesses
Table 108. Vetoquinol Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Vetoquinol Product
Table 110. Vetoquinol Recent Development
Table 111. Animalcare Group Corporation Information
Table 112. Animalcare Group Description and Major Businesses
Table 113. Animalcare Group Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Animalcare Group Product
Table 115. Animalcare Group Recent Development
Table 116. Ourofino Saude Animal Corporation Information
Table 117. Ourofino Saude Animal Description and Major Businesses
Table 118. Ourofino Saude Animal Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Ourofino Saude Animal Product
Table 120. Ourofino Saude Animal Recent Development
Table 121. Boehringer Ingelheim Corporation Information
Table 122. Boehringer Ingelheim Description and Major Businesses
Table 123. Boehringer Ingelheim Dog Prescription Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Boehringer Ingelheim Product
Table 125. Boehringer Ingelheim Recent Development
Table 126. Global Dog Prescription Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 127. Global Dog Prescription Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Dog Prescription Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Dog Prescription Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Dog Prescription Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 131. North America: Dog Prescription Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Dog Prescription Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 133. Europe: Dog Prescription Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Dog Prescription Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 135. Asia Pacific: Dog Prescription Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Dog Prescription Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 137. Latin America: Dog Prescription Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Dog Prescription Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 139. Middle East and Africa: Dog Prescription Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Dog Prescription Drugs Players
Table 144. Dog Prescription Drugs Customers List
Table 145. Dog Prescription Drugs Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Dog Prescription Drugs Product Picture
Figure 2. Global Dog Prescription Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Type Product Picture
Figure 4. Smear Type Product Picture
Figure 5. Injection Type Product Picture
Figure 6. Spray Type Product Picture
Figure 7. Global Dog Prescription Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Dog Prescription Drugs Report Years Considered
Figure 12. Global Dog Prescription Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Dog Prescription Drugs Sales 2015-2026 (K Units)
Figure 14. Global Dog Prescription Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Dog Prescription Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Dog Prescription Drugs Sales Market Share by Region in 2019
Figure 17. Global Dog Prescription Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Dog Prescription Drugs Revenue Market Share by Region in 2019
Figure 19. Global Dog Prescription Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Dog Prescription Drugs Revenue in 2019
Figure 21. Dog Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Dog Prescription Drugs Sales Market Share by Type in 2019
Figure 24. Global Dog Prescription Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Dog Prescription Drugs Revenue Market Share by Type in 2019
Figure 26. Global Dog Prescription Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Dog Prescription Drugs Sales Market Share by Application in 2019
Figure 29. Global Dog Prescription Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Dog Prescription Drugs Revenue Market Share by Application in 2019
Figure 31. North America Dog Prescription Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Dog Prescription Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Dog Prescription Drugs Sales Market Share by Country in 2019
Figure 34. North America Dog Prescription Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Dog Prescription Drugs Market Share by Type in 2019
Figure 40. North America Dog Prescription Drugs Market Share by Application in 2019
Figure 41. Europe Dog Prescription Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Dog Prescription Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Dog Prescription Drugs Sales Market Share by Country in 2019
Figure 44. Europe Dog Prescription Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Dog Prescription Drugs Market Share by Type in 2019
Figure 56. Europe Dog Prescription Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Dog Prescription Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Dog Prescription Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Dog Prescription Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Dog Prescription Drugs Revenue Market Share by Region in 2019
Figure 61. China Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Dog Prescription Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Dog Prescription Drugs Market Share by Application in 2019
Figure 85. Latin America Dog Prescription Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Dog Prescription Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Dog Prescription Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Dog Prescription Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Dog Prescription Drugs Market Share by Type in 2019
Figure 96. Latin America Dog Prescription Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Dog Prescription Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Dog Prescription Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Dog Prescription Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Dog Prescription Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Dog Prescription Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Dog Prescription Drugs Market Share by Application in 2019
Figure 109. Elanco Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. MSD Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Virbac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Dechra Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Vetoquinol Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Animalcare Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Ourofino Saude Animal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Dog Prescription Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. North America Dog Prescription Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Dog Prescription Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Europe Dog Prescription Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Dog Prescription Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Asia Pacific Dog Prescription Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Dog Prescription Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Latin America Dog Prescription Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Dog Prescription Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 128. Middle East and Africa Dog Prescription Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
Figure 1. Dog Prescription Drugs Product Picture
Figure 2. Global Dog Prescription Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Type Product Picture
Figure 4. Smear Type Product Picture
Figure 5. Injection Type Product Picture
Figure 6. Spray Type Product Picture
Figure 7. Global Dog Prescription Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Dog Prescription Drugs Report Years Considered
Figure 12. Global Dog Prescription Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Dog Prescription Drugs Sales 2015-2026 (K Units)
Figure 14. Global Dog Prescription Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Dog Prescription Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Dog Prescription Drugs Sales Market Share by Region in 2019
Figure 17. Global Dog Prescription Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Dog Prescription Drugs Revenue Market Share by Region in 2019
Figure 19. Global Dog Prescription Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Dog Prescription Drugs Revenue in 2019
Figure 21. Dog Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Dog Prescription Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Dog Prescription Drugs Sales Market Share by Type in 2019
Figure 24. Global Dog Prescription Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Dog Prescription Drugs Revenue Market Share by Type in 2019
Figure 26. Global Dog Prescription Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Dog Prescription Drugs Sales Market Share by Application in 2019
Figure 29. Global Dog Prescription Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Dog Prescription Drugs Revenue Market Share by Application in 2019
Figure 31. North America Dog Prescription Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Dog Prescription Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Dog Prescription Drugs Sales Market Share by Country in 2019
Figure 34. North America Dog Prescription Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Dog Prescription Drugs Market Share by Type in 2019
Figure 40. North America Dog Prescription Drugs Market Share by Application in 2019
Figure 41. Europe Dog Prescription Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Dog Prescription Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Dog Prescription Drugs Sales Market Share by Country in 2019
Figure 44. Europe Dog Prescription Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Dog Prescription Drugs Market Share by Type in 2019
Figure 56. Europe Dog Prescription Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Dog Prescription Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Dog Prescription Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Dog Prescription Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Dog Prescription Drugs Revenue Market Share by Region in 2019
Figure 61. China Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Dog Prescription Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Dog Prescription Drugs Market Share by Application in 2019
Figure 85. Latin America Dog Prescription Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Dog Prescription Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Dog Prescription Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Dog Prescription Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Dog Prescription Drugs Market Share by Type in 2019
Figure 96. Latin America Dog Prescription Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Dog Prescription Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Dog Prescription Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Dog Prescription Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Dog Prescription Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Dog Prescription Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Dog Prescription Drugs Market Share by Application in 2019
Figure 109. Elanco Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. MSD Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Virbac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Dechra Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Vetoquinol Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Animalcare Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Ourofino Saude Animal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Dog Prescription Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. North America Dog Prescription Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Dog Prescription Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Europe Dog Prescription Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Dog Prescription Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Asia Pacific Dog Prescription Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Dog Prescription Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Latin America Dog Prescription Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Dog Prescription Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 128. Middle East and Africa Dog Prescription Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
